Company: BIAF
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001641172-25-025990
Chunk: 4

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-29
Form: S-1
Chunk 4
---
, as applicable, to bear all of the expenses in connection with the registration of the Common Warrant Shares pursuant to this prospectus. The Selling Stockholders will pay or assume all commissions, discounts, fees of underwriters, agents, selling brokers or dealer managers and similar expenses, if any, attributable to their respective sales of the shares of Common Stock.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol “BIAF”. On August 26, 2025, the closing price of our Common Stock on the Nasdaq Capital Market was $0.2522 per share.

Investing in our securities involves risks. You should review carefully the risks and uncertainties described under the heading “ Risk Factors” contained in this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus, as described beginning on page7 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The securities are not being offered in any jurisdiction where the offer is not permitted.

<div align='center'>The date of this prospectus is , 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                      | Page |
| ABOUT THIS PROSPECTUS                                |   ii |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS |  iii |
| PROSPECTUS SUMMARY                                   |    1 |
| THE OFFERING                                         |    6 |
| RISK FACTORS                                         |    7 |
| THE PRIVATE PLACEMENTS                               |    9 |
| SELLING STOCKHOLDERS                                 |   12 |
| DESCRIPTION OF SECURITIES                            |   15 |
| PLAN OF DISTRIBUTION                                 |   20 |
| EXPERTS                                              |   21 |
| LEGAL MATTERS                                        |   21 |
| WHERE YOU CAN FIND ADDITIONAL INFORMATION            |   21 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE    |   22 |

The registration statement containing this prospectus, including the exhibits to the registration statement, provides additional information about us and the Common Stock offered under this prospectus. The registration statement, including the exhibits, can be read on our website and the website of the Securities and Exchange Commission. See “Where You Can Find Additional Information.”

Information contained in, and that can be accessed through our